The purpose of the Phagebiotics Research Foundation is to further medical and veterinary applications of bacteriophages to treat bacterial disorders. Bacteriophages, or phages, are viruses that infect and kill bacteria in very specific fashion. They have been used therapeutically in some parts of the world since the 1920s and are under renewed consideration worldwide as tools for fighting the growing crisis of antibiotics resistant bacteria. They support collaborative research that helps establish the safety and efficacy of phage therapy for key applications, working toward FDA approval of this approach. Their goals also include education regarding phage therapy for medical, scientific and general audiences and helping to develop the US infrastructure needed for its application.

The Phagebiotics Research Foundation studies and promotes medical and veterinary applications of bacteriophages in the treatment of bacterial disorders.
Their Principles:

• They are focused on development of bacteriophage therapy as a tool to combat the growing issue of antibiotic resistance.
• They support projects that provide the required knowledge and infrastructure foundation to carrying out physician-initiated controlled clinical trials both in the US and collaboratively with colleagues in foreign countries.
• As a nonprofit research foundation focused on science and community need, findings supported by their efforts will be publicly available for use to further develop the field.

Their goals:
Collaboration in Phage Therapy Research

• Supporting collaborative research that helps further clarify the safety and efficacy of phage therapy for key applications.
• Bringing together the medical and scientific communities across countries and disciplines in order to coordinate research efforts for greatest impact.
• Collaborating closely with other interested parties working towards widespread regulatory approval of phage based therapeutics.
• Developing a forum for the establishment of evidence based phage therapy clinical practice, and the clinical research needed to answer key “best practice” questions.

Education

• Supporting and providing phage therapy education for medical, scientific and general audiences.
  Helping to develop the medical and pharmaceutical infrastructure needed for the application of phage therapy.
• Developing a forum for the establishment of evidence based phage therapy clinical practice, and the clinical research needed to answer key “best practice” questions.